Thermo Fisher Announces Plans to Expand Sterile Filling Capacity for Vaccines and Therapies with New Facility in Singapore
To enhance our support for global health and preparedness in the Asia-Pacific region, Thermo Fisher announced plans to develop two new sterile filling lines in Singapore to extend capacity to the region for the development and manufacture of therapies and vaccines. Established with Singapore Economic Development Board (EDB) support, the new facility, operated by Thermo Fisher, will have the capability to manufacture pharmaceutical products to meet the demand in the region and respond effectively to health emergencies.
Learn More »
Thermo Fisher Pharma Services: COVID-19 Mobilization
We're working arm-in-arm with industry innovators, government agencies and academic institutions to provide scale, flexibility and expertise in the battle against COVID-19.
Learn More »
Make your Molecule a Medicine - Start with a Virtual Tour of our Sites
In this time of reduced travel and interpersonal contact, Patheon by Thermo Fisher Scientific is making it easier for you to actually see our facilities – from the inside out. Book a CPhI Virtual Meeting with us and take advantage of our Virtual Tour program: a 360-degree walking tour of many of our sites. See the highlights and features of the site and learn how we can help bring your molecule to life. We wouldn’t expect you to trust us with your project site unseen. So we can’t wait for you to see for yourself.
Book Your Meeting Now »
Thermo Fisher Scientific Opens New Bioprocessing Collaboration Center in St. Louis
The new Bioprocessing Collaboration Center (BCC) in St. Louis, Missouri, uniquely positions Thermo Fisher to bring together industry-leading expertise in single-use technologies and biologics product development and manufacturing to deliver unmatched value to our customers. The combined expertise from our bioproduction and pharma services businesses will accelerate innovation and enhance productivity for biopharma customers.
